• Edit
DateInvestorsAmountRound
-

N/A

-
N/A

$1.0m

Angel
N/A

$910k

Seed

$1.3m

Seed
N/A

N/A

Series B
N/A

N/A

Early VC

$10.0k

Grant

$6.6m

Series A
*
N/A

$5.0m

Early VC
Total FundingAUD22.9m

Recent News about Rimidi

Edit
More about Rimidiinfo icon
Edit

Rimidi operates in the healthcare technology sector, offering cloud-based clinical decision support and remote patient monitoring solutions. The company primarily serves healthcare providers, including clinicians and medical institutions, focusing on chronic disease management such as diabetes, cardiovascular disease, heart failure, nonalcoholic fatty liver disease, and obesity. Rimidi's platform integrates seamlessly into existing clinical workflows, providing personalized treatment recommendations and medication modeling based on aggregated patient data. This data-driven approach helps clinicians identify patients at high risk for worsening conditions or complications, enabling timely interventions. Rimidi's business model revolves around a subscription-based service, where healthcare providers pay for access to the platform and its various features. The company generates revenue through these subscriptions and potentially through additional services such as data analytics and custom integrations.

Keywords: healthcare technology, clinical decision support, remote patient monitoring, chronic disease management, cloud-based, data-driven, risk stratification, personalized treatment, subscription model, FHIR technology.

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.